EEPD1
gene geneOn this page
Also known as KIAA1706
Summary
EEPD1 (endonuclease/exonuclease/phosphatase family domain containing 1, HGNC:22223) is a protein-coding gene on chromosome 7p14.2, encoding Endonuclease/exonuclease/phosphatase family domain-containing protein 1 (Q7L9B9).
Predicted to enable DNA binding activity and catalytic activity. Involved in positive regulation of cholesterol efflux. Located in plasma membrane.
Source: NCBI Gene 80820 — RefSeq curated summary.
At a glance
- GWAS associations: 16
- Clinical variants (ClinVar): 106 total
- MANE Select transcript:
NM_030636
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:22223 |
| Approved symbol | EEPD1 |
| Name | endonuclease/exonuclease/phosphatase family domain containing 1 |
| Location | 7p14.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | KIAA1706 |
| Ensembl gene | ENSG00000122547 |
| Ensembl biotype | protein_coding |
| OMIM | 617192 |
| Entrez | 80820 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 8 protein_coding, 2 retained_intron
ENST00000242108, ENST00000444777, ENST00000468591, ENST00000487069, ENST00000874230, ENST00000874231, ENST00000874232, ENST00000936250, ENST00000960495, ENST00000960496
RefSeq mRNA: 1 — MANE Select: NM_030636
NM_030636
CCDS: CCDS34619
Canonical transcript exons
ENST00000242108 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000976554 | 36238985 | 36239036 |
| ENSE00001152794 | 36281115 | 36281225 |
| ENSE00001152811 | 36153254 | 36153674 |
| ENSE00001155725 | 36299007 | 36301538 |
| ENSE00001155731 | 36154133 | 36155202 |
| ENSE00003518739 | 36296993 | 36297187 |
| ENSE00003589096 | 36287639 | 36287777 |
| ENSE00003688602 | 36284686 | 36284820 |
Expression profiles
Bgee: expression breadth ubiquitous, 219 present calls, max score 96.35.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 7.7982 / max 178.4895, expressed in 1371 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 78119 | 4.8093 | 1140 |
| 78125 | 1.0721 | 393 |
| 78118 | 0.7578 | 419 |
| 78124 | 0.6166 | 270 |
| 78132 | 0.2125 | 78 |
| 78126 | 0.1815 | 82 |
| 78131 | 0.0634 | 30 |
| 78133 | 0.0464 | 15 |
| 78134 | 0.0386 | 5 |
Top tissues by expression
243 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ventricular zone | UBERON:0003053 | 96.35 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 93.98 | gold quality |
| gastrocnemius | UBERON:0001388 | 93.89 | gold quality |
| muscle of leg | UBERON:0001383 | 93.04 | gold quality |
| gall bladder | UBERON:0002110 | 90.98 | gold quality |
| ganglionic eminence | UBERON:0004023 | 90.96 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 90.59 | gold quality |
| body of stomach | UBERON:0001161 | 89.75 | gold quality |
| omental fat pad | UBERON:0010414 | 89.58 | gold quality |
| peritoneum | UBERON:0002358 | 89.48 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 89.26 | gold quality |
| right lobe of liver | UBERON:0001114 | 89.23 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 89.22 | gold quality |
| lower esophagus | UBERON:0013473 | 89.20 | gold quality |
| adipose tissue of abdominal region | UBERON:0007808 | 88.93 | gold quality |
| pancreatic ductal cell | CL:0002079 | 88.53 | silver quality |
| apex of heart | UBERON:0002098 | 88.41 | gold quality |
| skin of abdomen | UBERON:0001416 | 87.99 | gold quality |
| body of pancreas | UBERON:0001150 | 87.89 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 87.72 | gold quality |
| endocervix | UBERON:0000458 | 87.37 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 87.30 | gold quality |
| skin of leg | UBERON:0001511 | 87.25 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 87.17 | gold quality |
| spinal cord | UBERON:0002240 | 87.04 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 86.97 | gold quality |
| stomach | UBERON:0000945 | 86.57 | gold quality |
| popliteal artery | UBERON:0002250 | 86.46 | gold quality |
| tibial artery | UBERON:0007610 | 86.44 | gold quality |
| tibialis anterior | UBERON:0001385 | 86.10 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.63 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
81 targeting EEPD1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4747-5P | 100.00 | 67.90 | 2681 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-4673 | 100.00 | 66.64 | 1490 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4481 | 100.00 | 66.42 | 1669 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-4645-5P | 99.98 | 65.81 | 1284 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-3065-5P | 99.97 | 71.56 | 3281 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-6825-5P | 99.96 | 69.81 | 3431 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-3686 | 99.90 | 70.53 | 2432 |
| HSA-MIR-3529-3P | 99.90 | 73.55 | 3045 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-4779 | 99.86 | 66.50 | 1583 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
Literature-anchored findings (GeneRIF, showing 5)
- These data demonstrate that genome stability during replication stress is maintained by EEPD1, which initiates HR and inhibits cNHEJ and MMEJ. (PMID:26684013)
- EEPD1 performs a gatekeeper function for replication fork repair by mediating the fork cleavage that permits initiation of HR-mediated repair and restart of stressed forks (PMID:28049724)
- EEPD1 is a novel LXR-regulated gene in macrophages and that it promotes cellular cholesterol efflux by controlling cellular levels and activity of ABCA1. (PMID:28082258)
- The mechanism by which RAD52 depletion causes synthetic lethality in BRCA1 mutant cancer cells depends on the 5’ endonuclease EEPD1, which normally functions to cleave stressed replication forks to initiate HR repair. (PMID:29145865)
- Super-enhancer-associated EEPD1 facilitates EMT-mediated metastasis by regulating the PI3K/AKT/mTOR pathway in gastric cancer. (PMID:37976838)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | eepd1 | ENSDARG00000071116 |
| mus_musculus | Eepd1 | ENSMUSG00000036611 |
| rattus_norvegicus | Eepd1 | ENSRNOG00000006931 |
Protein
Protein identifiers
Endonuclease/exonuclease/phosphatase family domain-containing protein 1 — Q7L9B9 (reviewed: Q7L9B9)
All UniProt accessions (2): H7C4A5, Q7L9B9
UniProt curated annotations — full annotation on UniProt →
RefSeq proteins (1): NP_085139* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003583 | Hlx-hairpin-Hlx_DNA-bd_motif | Domain |
| IPR004509 | Competence_ComEA_HhH | Domain |
| IPR005135 | Endo/exonuclease/phosphatase | Domain |
| IPR010994 | RuvA_2-like | Homologous_superfamily |
| IPR036691 | Endo/exonu/phosph_ase_sf | Homologous_superfamily |
| IPR051675 | Endo/Exo/Phosphatase_dom_1 | Family |
Pfam: PF03372, PF12836
UniProt features (22 total): modified residue 9, sequence variant 3, region of interest 3, compositionally biased region 3, initiator methionine 1, chain 1, lipid moiety-binding region 1, domain 1
Structure
Experimental structures (PDB)
3 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9YSF | X-RAY DIFFRACTION | 1.59 |
| 9YXY | X-RAY DIFFRACTION | 2 |
| 9YI2 | ELECTRON MICROSCOPY | 3.6 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7L9B9-F1 | 74.72 | 0.40 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (10): 21, 25, 106, 110, 160, 173, 265, 428, 2, 16
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-9029569 | NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux |
MSigDB gene sets: 146 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN, GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX, GOBP_REGULATION_OF_CHOLESTEROL_EFFLUX, GOBP_POSITIVE_REGULATION_OF_STEROL_TRANSPORT, GOBP_POSITIVE_REGULATION_OF_LIPID_TRANSPORT, GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT, GOBP_CHOLESTEROL_EFFLUX, RGTTAMWNATT_HNF1_01, GOBP_DNA_DAMAGE_RESPONSE, GOBP_REGULATION_OF_STEROL_TRANSPORT, HNF1_C, GOBP_STEROL_TRANSPORT, HNF1_01, GOBP_POSITIVE_REGULATION_OF_TRANSPORT, GOBP_REGULATION_OF_TRANSPORT
GO Biological Process (2): DNA repair (GO:0006281), positive regulation of cholesterol efflux (GO:0010875)
GO Molecular Function (3): DNA binding (GO:0003677), catalytic activity (GO:0003824), protein binding (GO:0005515)
GO Cellular Component (1): plasma membrane (GO:0005886)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| NR1H2 and NR1H3-mediated signaling | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA metabolic process | 1 |
| DNA damage response | 1 |
| regulation of cholesterol efflux | 1 |
| positive regulation of cholesterol transport | 1 |
| cholesterol efflux | 1 |
| nucleic acid binding | 1 |
| molecular_function | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
Protein interactions and networks
STRING
1404 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| EEPD1 | EXO1 | Q9UQ84 | 676 |
| EEPD1 | EME2 | A4GXA9 | 534 |
| EEPD1 | DNA2 | P51530 | 469 |
| EEPD1 | EXO5 | Q9H790 | 456 |
| EEPD1 | SHISA3 | A0PJX4 | 453 |
| EEPD1 | SETMAR | Q53H47 | 433 |
| EEPD1 | MUS81 | Q96NY9 | 433 |
| EEPD1 | TXNDC8 | Q6A555 | 423 |
| EEPD1 | RAD52 | P43351 | 419 |
| EEPD1 | COX7A2L | O14548 | 370 |
| EEPD1 | ADGRL1 | O94910 | 353 |
| EEPD1 | ADGRL2 | O95490 | 353 |
| EEPD1 | ADGRL3 | Q9HAR2 | 353 |
| EEPD1 | FHIP2A | Q5W0V3 | 350 |
| EEPD1 | MTMR8 | Q96EF0 | 347 |
IntAct
36 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MED21 | MED19 | psi-mi:“MI:0914”(association) | 0.880 |
| EEPD1 | GRIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FYTTD1 | UBA6 | psi-mi:“MI:0914”(association) | 0.530 |
| GJB7 | PALM3 | psi-mi:“MI:0914”(association) | 0.530 |
| FSD1 | UBFD1 | psi-mi:“MI:0914”(association) | 0.530 |
| RSBN1 | SETD1A | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM185A | TSPAN6 | psi-mi:“MI:0914”(association) | 0.530 |
| EEPD1 | psi-mi:“MI:0407”(direct interaction) | 0.440 | |
| MED21 | MED19 | psi-mi:“MI:0914”(association) | 0.350 |
| TIGD5 | P4HA2 | psi-mi:“MI:0914”(association) | 0.350 |
| SDC1 | ARVCF | psi-mi:“MI:0914”(association) | 0.350 |
| PCDHGC3 | HRAS | psi-mi:“MI:0914”(association) | 0.350 |
| NCSTN | YES1 | psi-mi:“MI:0914”(association) | 0.350 |
| ISG20 | SRC | psi-mi:“MI:0914”(association) | 0.350 |
| ZBTB18 | DNASE1L1 | psi-mi:“MI:0914”(association) | 0.350 |
| CERS2 | VPS37C | psi-mi:“MI:0914”(association) | 0.350 |
| MALL | GPR89A | psi-mi:“MI:0914”(association) | 0.350 |
| ANKRD50 | PPP1R12A | psi-mi:“MI:0914”(association) | 0.350 |
| GAGE5 | PPP1R12A | psi-mi:“MI:0914”(association) | 0.350 |
| DPM2 | WDR46 | psi-mi:“MI:0914”(association) | 0.350 |
| STARD6 | GSTA4 | psi-mi:“MI:0914”(association) | 0.350 |
| FEM1A | RNF113A | psi-mi:“MI:0914”(association) | 0.350 |
| PIGT | AKAP8 | psi-mi:“MI:0914”(association) | 0.350 |
| PCDHGC3 | FYN | psi-mi:“MI:0914”(association) | 0.350 |
| NCSTN | ALOX5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (48): EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-MS), EEPD1 (Affinity Capture-RNA)
ESM2 similar proteins: A0A2R8Y7D0, A3KMV1, A6NDN8, B9EHT4, D3YWQ0, F1MAB7, O23702, O54788, O75426, O76075, P04413, P0C5J9, P49897, P55073, Q1LZC5, Q28969, Q2T9Z2, Q2VPJ9, Q39491, Q3MHJ7, Q3TGW2, Q4R327, Q57VU6, Q58CZ0, Q5BIR3, Q5I3B1, Q5R4R7, Q5R686, Q5SPX3, Q5XI74, Q6DN07, Q6NXT1, Q6P7W2, Q6QN11, Q6X4W1, Q7L9B9, Q7TPD7, Q80TL4, Q8K485, Q8TBC3
Diamond homologs: A6QPL4, P0AAR8, P0AAR9, P39694, Q14807, Q3MHJ7, Q3TGW2, Q3V300, Q57134, Q5I0E8, Q5REP4, Q5XI74, Q6P3R1, Q6TEQ0, Q7L9B9, A8WFU8, P46837, P57072, P71353, Q45388, Q497V5, Q51062, Q51152, Q5RDI0, Q6IND4, Q8N5C6, Q9I869
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
106 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 93 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2715 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:36164806:G:GG | donor_gain | 1.0000 |
| 7:36238983:A:AG | acceptor_gain | 1.0000 |
| 7:36238983:AG:A | acceptor_loss | 1.0000 |
| 7:36238984:G:GC | acceptor_loss | 1.0000 |
| 7:36238984:G:GG | acceptor_gain | 1.0000 |
| 7:36238984:GC:G | acceptor_gain | 1.0000 |
| 7:36243866:G:GT | donor_gain | 1.0000 |
| 7:36281113:A:AG | acceptor_gain | 1.0000 |
| 7:36281114:G:GG | acceptor_gain | 1.0000 |
| 7:36281221:AGAAG:A | donor_loss | 1.0000 |
| 7:36281222:GAAGG:G | donor_loss | 1.0000 |
| 7:36281223:AAGGT:A | donor_loss | 1.0000 |
| 7:36281224:AGGTA:A | donor_loss | 1.0000 |
| 7:36281225:GGTA:G | donor_loss | 1.0000 |
| 7:36281226:GT:G | donor_loss | 1.0000 |
| 7:36281227:T:G | donor_loss | 1.0000 |
| 7:36284781:G:T | donor_gain | 1.0000 |
| 7:36284815:TTC:T | donor_gain | 1.0000 |
| 7:36284872:A:T | donor_gain | 1.0000 |
| 7:36296985:A:AG | acceptor_gain | 1.0000 |
| 7:36296986:C:G | acceptor_gain | 1.0000 |
| 7:36296988:TCCAG:T | acceptor_loss | 1.0000 |
| 7:36296991:A:AG | acceptor_gain | 1.0000 |
| 7:36296991:AGG:A | acceptor_loss | 1.0000 |
| 7:36296992:G:A | acceptor_loss | 1.0000 |
| 7:36296992:G:GA | acceptor_gain | 1.0000 |
| 7:36296992:GGA:G | acceptor_gain | 1.0000 |
| 7:36297160:A:AG | donor_gain | 1.0000 |
| 7:36297161:G:GG | donor_gain | 1.0000 |
| 7:36297189:T:A | donor_loss | 1.0000 |
AlphaMissense
3739 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 7:36154449:T:A | I42N | 1.000 |
| 7:36154453:C:A | N43K | 1.000 |
| 7:36154453:C:G | N43K | 1.000 |
| 7:36154458:C:A | A45D | 1.000 |
| 7:36154473:T:A | L50Q | 1.000 |
| 7:36154473:T:C | L50P | 1.000 |
| 7:36154482:T:C | L53P | 1.000 |
| 7:36154506:C:A | A61E | 1.000 |
| 7:36154515:T:A | I64N | 1.000 |
| 7:36154527:G:C | R68P | 1.000 |
| 7:36154544:T:C | F74L | 1.000 |
| 7:36154545:T:C | F74S | 1.000 |
| 7:36154546:C:A | F74L | 1.000 |
| 7:36154546:C:G | F74L | 1.000 |
| 7:36154563:T:C | L80P | 1.000 |
| 7:36154572:T:A | V83D | 1.000 |
| 7:36154596:T:C | L91P | 1.000 |
| 7:36154449:T:G | I42S | 0.999 |
| 7:36154452:A:T | N43I | 0.999 |
| 7:36154457:G:C | A45P | 0.999 |
| 7:36154473:T:G | L50R | 0.999 |
| 7:36154505:G:C | A61P | 0.999 |
| 7:36154515:T:G | I64S | 0.999 |
| 7:36154523:T:G | Y67D | 0.999 |
| 7:36154526:C:G | R68G | 0.999 |
| 7:36154544:T:G | F74V | 0.999 |
| 7:36154545:T:G | F74C | 0.999 |
| 7:36154559:G:C | D79H | 0.999 |
| 7:36154560:A:C | D79A | 0.999 |
| 7:36154560:A:G | D79G | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000011213 (7:36228028 T>C), RS1000013117 (7:36191917 C>A,T), RS1000047791 (7:36269693 T>C), RS1000115245 (7:36185769 C>T), RS1000141587 (7:36228060 C>T), RS1000177805 (7:36217476 C>T), RS1000178127 (7:36262705 C>G,T), RS1000195956 (7:36239825 A>C,T), RS1000201432 (7:36256832 A>C), RS1000211484 (7:36203825 C>T), RS1000222926 (7:36178742 C>T), RS1000266499 (7:36206027 G>T), RS1000309449 (7:36297338 T>C), RS1000313639 (7:36161053 G>A), RS1000322853 (7:36301983 T>C)
Disease associations
OMIM: gene MIM:617192 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
16 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001061_6 | Platelet count | 5.000000e-06 |
| GCST001762_559 | Obesity-related traits | 3.000000e-06 |
| GCST003194_24 | Fibrinogen levels | 3.000000e-09 |
| GCST004121_32 | Fibrinogen levels | 4.000000e-08 |
| GCST004122_6 | Fibrinogen levels | 9.000000e-09 |
| GCST006626_16 | Pulse pressure | 1.000000e-09 |
| GCST007205_6 | Schizophrenia | 1.000000e-06 |
| GCST007614_47 | C-reactive protein levels | 1.000000e-08 |
| GCST010002_347 | Refractive error | 3.000000e-08 |
| GCST010241_425 | Apolipoprotein A1 levels | 2.000000e-12 |
| GCST010242_18 | HDL cholesterol levels | 1.000000e-16 |
| GCST010242_242 | HDL cholesterol levels | 1.000000e-08 |
| GCST010245_60 | LDL cholesterol levels | 2.000000e-11 |
| GCST90002385_186 | High light scatter reticulocyte count | 6.000000e-10 |
| GCST90002397_500 | Mean spheric corpuscular volume | 2.000000e-12 |
| GCST90002405_227 | Reticulocyte count | 7.000000e-10 |
EFO canonical traits (8, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
| EFO:0004736 | aspartate aminotransferase measurement |
| EFO:0005763 | pulse pressure measurement |
| EFO:0004458 | C-reactive protein measurement |
| EFO:0004614 | apolipoprotein A 1 measurement |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
| EFO:0004611 | low density lipoprotein cholesterol measurement |
| EFO:0007986 | reticulocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
44 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression, increases methylation | 3 |
| Lead | affects expression, affects methylation | 2 |
| Tobacco Smoke Pollution | decreases expression | 2 |
| Aflatoxin B1 | decreases methylation, increases methylation | 2 |
| aristolochic acid I | increases expression | 1 |
| FR900359 | affects phosphorylation | 1 |
| dicrotophos | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| sodium arsenite | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | decreases expression, decreases reaction | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| NSC 689534 | affects binding, decreases expression | 1 |
| Leflunomide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Air Pollutants | increases abundance, affects expression | 1 |
| Amiodarone | increases expression | 1 |
| Arbutin | increases expression | 1 |
| Arsenic | affects methylation | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Caffeine | decreases phosphorylation | 1 |
| Calcitriol | decreases expression | 1 |
| Cisplatin | increases expression | 1 |
| Copper | affects binding, decreases expression | 1 |
| Dexamethasone | increases expression | 1 |
| Estradiol | affects expression | 1 |
| Lipopolysaccharides | decreases expression, decreases reaction | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.